Mazor Robotics’ Renaissance Technology Receives U.S. FDA Clearance for Brain Applications

CAESAREA, Israel — (BUSINESS WIRE) — July 16, 2012 — Mazor Robotics Ltd. (TASE: MZOR), a developer of innovative surgical robots and complementary products, today announced its Renaissance™ platform received U.S. FDA marketing clearance, expanding the applications of the Renaissance system to include the precise positioning of surgical instruments and implants during brain surgery.

The Renaissance technology, a surgical guidance system originally designed for use in spine surgeries, is applicable in brain procedures for many applications including biopsies, shunt placements and neurostimulation electrode placement for deep brain stimulation (DBS). Along with the system’s precision, simplicity, and safety profile, the Renaissance System will also provide a frameless treatment solution for brain procedures. Renaissance has already been successfully employed in several clinical brain surgical procedures in Europe. 34 hospitals globally are currently using Renaissance for the different types of spine surgery.

“While our core is spine surgery, we are thrilled that our technology can be expanded to improve other surgical procedures,” stated Ori Hadomi, chief executive officer. “As neurosurgeons focus on both the spine and brain, brain surgeries represent a large market opportunity that is closely aligned with our current focus. Achieving U.S. regulatory clearance provides us with the opportunity to assist neurosurgeons in improving brain surgery processes and the ensuing clinical outcomes.”

About Mazor

Mazor Robotics (TASE: MZOR) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 20,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, please visit www.mazorrobotics.com.



Contact:

Investors
EVC Group
Robert Jones/Aimee Gordon, 646-201-5447
Email Contact/ Email Contact
or
Media
EVC Group
Steve DiMattia, 646-201-5445
Email Contact




Review Article Be the first to review this article
Autodesk - DelCAM

Editorial
Jeff RoweJeff's MCAD Blogging
by Jeff Rowe
Hexagon’s Recent Ups & Downs Update
Jobs
Solidworks Product Designer for NASCENT Technology at Charlotte, NC
Developer-Support-Implementation Engineer for EDA Careers at San Francisco Area, CA
SYSTEMS INTEGRATOR for Palm Beach County Human Resources at West Palm Beach, FL
CAD/CAM Regional Account Manager (Pacific Northwest) for Vero Software Inc. at Seattle, WA
Upcoming Events
AI·GI·CRV Conference 2017 at Edmonton, Alberta Canada - May 16 - 19, 2017
Innorobo 2017 at Docks de Paris Paris France - May 16 - 18, 2017
Display Week 2017 at Los Angeles Convention Center 1201 S Figueroa St Los Angeles CA - May 21 - 26, 2017
LiveWorx Tech Conf 2017 at Boston MA - May 22 - 25, 2017
SolidCAM: Patented Wizard to optimal feeds & speeds



Internet Business Systems © 2017 Internet Business Systems, Inc.
595 Millich Dr., Suite 216, Campbell, CA 95008
+1 (408)-337-6870 — Contact Us, or visit our other sites:
AECCafe - Architectural Design and Engineering EDACafe - Electronic Design Automation GISCafe - Geographical Information Services TechJobsCafe - Technical Jobs and Resumes ShareCG - Share Computer Graphic (CG) Animation, 3D Art and 3D Models
  Privacy Policy Advertise